REGN logo

REGN Total expenses

Annual total expenses:

$10.11B+$1.23B(+13.80%)
December 31, 2024

Summary

  • As of today (May 29, 2025), REGN annual total expenses is $10.11 billion, with the most recent change of +$1.23 billion (+13.80%) on December 31, 2024.
  • During the last 3 years, REGN annual total expenses has risen by +$3.03 billion (+42.86%).
  • REGN annual total expenses is now at all-time high.

Performance

REGN Total expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNincome statement metrics

Quarterly total expenses:

$2.44B-$362.00M(-12.93%)
March 31, 2025

Summary

  • As of today (May 29, 2025), REGN quarterly total expenses is $2.44 billion, with the most recent change of -$362.00 million (-12.93%) on March 31, 2025.
  • Over the past year, REGN quarterly total expenses has increased by +$43.40 million (+1.81%).
  • REGN quarterly total expenses is now -12.93% below its all-time high of $2.80 billion, reached on December 31, 2024.

Performance

REGN Quarterly total expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNincome statement metrics

Total expenses Formula

Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses

REGN Total expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+13.8%+1.8%
3 y3 years+42.9%+42.8%
5 y5 years+132.5%+116.0%

REGN Total expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+42.9%-12.9%+42.8%
5 y5-yearat high+132.5%-12.9%+116.0%
alltimeall timeat high>+9999.0%-12.9%+785.5%

REGN Total expenses History

DateAnnualQuarterly
Mar 2025
-
$2.44B(-12.9%)
Dec 2024
$10.11B(+13.8%)
$2.80B(+10.1%)
Sep 2024
-
$2.54B(+2.6%)
Jun 2024
-
$2.48B(+3.5%)
Mar 2024
-
$2.39B(-2.8%)
Dec 2023
$8.88B(+23.8%)
$2.46B(+9.3%)
Sep 2023
-
$2.25B(+5.1%)
Jun 2023
-
$2.14B(-3.3%)
Mar 2023
-
$2.22B(-2.3%)
Dec 2022
$7.18B(+1.4%)
$2.27B(+32.4%)
Sep 2022
-
$1.71B(-2.0%)
Jun 2022
-
$1.75B(+2.4%)
Mar 2022
-
$1.71B(-26.2%)
Dec 2021
$7.08B(+43.8%)
$2.31B(+44.0%)
Sep 2021
-
$1.61B(-10.4%)
Jun 2021
-
$1.79B(+26.5%)
Mar 2021
-
$1.42B(+12.7%)
Dec 2020
$4.92B(+13.2%)
$1.26B(+1.2%)
Sep 2020
-
$1.24B(-4.2%)
Jun 2020
-
$1.30B(+14.8%)
Mar 2020
-
$1.13B(-5.0%)
Dec 2019
$4.35B(+66.5%)
$1.19B(+18.2%)
Sep 2019
-
$1.01B(-20.4%)
Jun 2019
-
$1.26B(+41.4%)
Mar 2019
-
$892.60M(-351.1%)
Dec 2018
$2.61B(-31.2%)
-$355.50M(-134.3%)
Sep 2018
-
$1.04B(+5.2%)
Jun 2018
-
$985.80M(+4.4%)
Mar 2018
-
$944.30M(-9.5%)
Dec 2017
$3.79B(+7.4%)
$1.04B(+10.9%)
Sep 2017
-
$940.75M(+2.3%)
Jun 2017
-
$919.80M(+3.5%)
Mar 2017
-
$888.45M(+1.0%)
Dec 2016
$3.53B(+23.8%)
$879.84M(+2.6%)
Sep 2016
-
$857.32M(-6.9%)
Jun 2016
-
$921.00M(+5.7%)
Mar 2016
-
$871.54M(+0.5%)
Dec 2015
$2.85B(+42.9%)
$867.00M(+16.4%)
Sep 2015
-
$745.00M(+14.0%)
Jun 2015
-
$653.76M(+11.6%)
Mar 2015
-
$586.06M(-0.1%)
Dec 2014
$2.00B(+46.6%)
$586.53M(+9.2%)
Sep 2014
-
$537.32M(+22.8%)
Jun 2014
-
$437.61M(+0.8%)
Mar 2014
-
$434.18M(+4.5%)
Dec 2013
$1.36B(+47.9%)
$415.32M(+15.3%)
Sep 2013
-
$360.23M(+20.3%)
Jun 2013
-
$299.54M(+4.5%)
Mar 2013
-
$286.61M(+6.6%)
Dec 2012
$920.76M(+41.4%)
$268.93M(+19.4%)
Sep 2012
-
$225.32M(+3.9%)
Jun 2012
-
$216.92M(+3.5%)
Mar 2012
-
$209.59M(+24.5%)
Dec 2011
$650.98M(+17.0%)
$168.38M(+4.4%)
Sep 2011
-
$161.29M(-4.1%)
Jun 2011
-
$168.13M(+9.8%)
Mar 2011
-
$153.19M(+4.6%)
Dec 2010
$556.55M(+22.8%)
$146.45M(+6.1%)
Sep 2010
-
$138.07M(-1.1%)
Jun 2010
-
$139.61M(+5.4%)
Mar 2010
-
$132.41M(-2.8%)
Dec 2009
$453.37M(+39.6%)
$136.21M(+14.7%)
Sep 2009
-
$118.75M(+11.7%)
Jun 2009
-
$106.30M(+15.4%)
Mar 2009
-
$92.12M(+6.1%)
Dec 2008
$324.71M
$86.86M(+1.6%)
Sep 2008
-
$85.52M(+6.5%)
Jun 2008
-
$80.27M(+11.0%)
DateAnnualQuarterly
Mar 2008
-
$72.29M(-5.2%)
Dec 2007
$239.48M(+40.0%)
$76.26M(+25.1%)
Sep 2007
-
$60.98M(+15.5%)
Jun 2007
-
$52.80M(+6.8%)
Mar 2007
-
$49.44M(+12.8%)
Dec 2006
$171.10M(-393.8%)
$43.83M(-0.1%)
Sep 2006
-
$43.88M(+0.9%)
Jun 2006
-
$43.51M(+9.1%)
Mar 2006
-
$39.88M(-119.8%)
Dec 2005
-$58.23M(-134.6%)
-$201.89M(-499.1%)
Sep 2005
-
$50.58M(+4.2%)
Jun 2005
-
$48.53M(+8.9%)
Mar 2005
-
$44.55M(+3.3%)
Dec 2004
$168.37M(+6.9%)
$43.12M(-6.3%)
Sep 2004
-
$46.00M(+12.0%)
Jun 2004
-
$41.06M(+7.5%)
Mar 2004
-
$38.20M(-0.6%)
Dec 2003
$157.49M(+9.4%)
$38.41M(-10.9%)
Sep 2003
-
$43.09M(+15.0%)
Jun 2003
-
$37.46M(-2.7%)
Mar 2003
-
$38.52M(-2.6%)
Dec 2002
$143.94M(+33.7%)
$39.54M(+2.1%)
Sep 2002
-
$38.74M(+9.1%)
Jun 2002
-
$35.52M(+17.9%)
Mar 2002
-
$30.13M(-11.4%)
Dec 2001
$107.66M(+27.3%)
$33.99M(+18.1%)
Sep 2001
-
$28.77M(+20.6%)
Jun 2001
-
$23.86M(+13.5%)
Mar 2001
-
$21.02M(-27.3%)
Dec 2000
$84.55M(+45.0%)
$28.93M(-5.1%)
Sep 2000
-
$30.49M(+65.4%)
Jun 2000
-
$18.43M(-2.9%)
Mar 2000
-
$18.98M(+50.6%)
Dec 1999
$58.30M(+14.8%)
$12.60M(-23.2%)
Sep 1999
-
$16.40M(+14.7%)
Jun 1999
-
$14.30M(-9.5%)
Mar 1999
-
$15.80M(+16.2%)
Dec 1998
$50.80M(+25.1%)
$13.60M(+3.0%)
Sep 1998
-
$13.20M(+3.1%)
Jun 1998
-
$12.80M(+12.3%)
Mar 1998
-
$11.40M(+11.8%)
Dec 1997
$40.60M(-1.9%)
$10.20M(+2.0%)
Sep 1997
-
$10.00M(-2.9%)
Jun 1997
-
$10.30M(0.0%)
Mar 1997
-
$10.30M(-6.4%)
Dec 1996
$41.40M(+18.3%)
$11.00M(+3.8%)
Sep 1996
-
$10.60M(+7.1%)
Jun 1996
-
$9.90M(0.0%)
Mar 1996
-
$9.90M(+16.5%)
Dec 1995
$35.00M(-33.2%)
$8.50M(-1.2%)
Sep 1995
-
$8.60M(-3.4%)
Jun 1995
-
$8.90M(-1.1%)
Mar 1995
-
$9.00M(-29.7%)
Dec 1994
$52.40M(+6.1%)
$12.80M(+1.6%)
Sep 1994
-
$12.60M(-7.4%)
Jun 1994
-
$13.60M(+1.5%)
Mar 1994
-
$13.40M(-5.0%)
Dec 1993
$49.40M(+65.8%)
$14.10M(+9.3%)
Sep 1993
-
$12.90M(+16.2%)
Jun 1993
-
$11.10M(-1.8%)
Mar 1993
-
$11.30M(+34.5%)
Dec 1992
$29.80M(+76.3%)
$8.40M(+5.0%)
Sep 1992
-
$8.00M(+19.4%)
Jun 1992
-
$6.70M(0.0%)
Mar 1992
-
$6.70M(+17.5%)
Dec 1991
$16.90M(+103.6%)
$5.70M(+29.5%)
Sep 1991
-
$4.40M(+18.9%)
Jun 1991
-
$3.70M
Dec 1990
$8.30M
-

FAQ

  • What is Regeneron Pharmaceuticals annual total expenses?
  • What is the all time high annual total expenses for Regeneron Pharmaceuticals?
  • What is Regeneron Pharmaceuticals annual total expenses year-on-year change?
  • What is Regeneron Pharmaceuticals quarterly total expenses?
  • What is the all time high quarterly total expenses for Regeneron Pharmaceuticals?
  • What is Regeneron Pharmaceuticals quarterly total expenses year-on-year change?

What is Regeneron Pharmaceuticals annual total expenses?

The current annual total expenses of REGN is $10.11B

What is the all time high annual total expenses for Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals all-time high annual total expenses is $10.11B

What is Regeneron Pharmaceuticals annual total expenses year-on-year change?

Over the past year, REGN annual total expenses has changed by +$1.23B (+13.80%)

What is Regeneron Pharmaceuticals quarterly total expenses?

The current quarterly total expenses of REGN is $2.44B

What is the all time high quarterly total expenses for Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals all-time high quarterly total expenses is $2.80B

What is Regeneron Pharmaceuticals quarterly total expenses year-on-year change?

Over the past year, REGN quarterly total expenses has changed by +$43.40M (+1.81%)
On this page